Chugai Pharmaceutical Statistics
Total Valuation
CHGCF has a market cap or net worth of 92.46 billion. The enterprise value is 85.84 billion.
| Market Cap | 92.46B |
| Enterprise Value | 85.84B |
Important Dates
The last earnings date was Thursday, April 24, 2025.
| Earnings Date | Apr 24, 2025 |
| Ex-Dividend Date | Dec 27, 2024 |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.01% |
| Shares Change (QoQ) | -0.03% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 639.69M |
Valuation Ratios
The trailing PE ratio is 33.76.
| PE Ratio | 33.76 |
| Forward PE | n/a |
| PS Ratio | 11.33 |
| PB Ratio | 7.26 |
| P/TBV Ratio | 7.33 |
| P/FCF Ratio | 39.24 |
| P/OCF Ratio | 33.50 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 20.07, with an EV/FCF ratio of 36.43.
| EV / Earnings | 31.34 |
| EV / Sales | 10.02 |
| EV / EBITDA | 20.07 |
| EV / EBIT | 21.17 |
| EV / FCF | 36.43 |
Financial Position
The company has a current ratio of 7.28
| Current Ratio | 7.28 |
| Quick Ratio | 5.95 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 23.11% and return on invested capital (ROIC) is 20.38%.
| Return on Equity (ROE) | 23.11% |
| Return on Assets (ROA) | 17.92% |
| Return on Invested Capital (ROIC) | 20.38% |
| Return on Capital Employed (ROCE) | 29.97% |
| Revenue Per Employee | 1.62M |
| Profits Per Employee | 544,953 |
| Employee Count | 5,026 |
| Asset Turnover | 0.61 |
| Inventory Turnover | 1.39 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +85.01% in the last 52 weeks. The beta is 0.70, so CHGCF's price volatility has been lower than the market average.
| Beta (5Y) | 0.70 |
| 52-Week Price Change | +85.01% |
| 50-Day Moving Average | 47.51 |
| 200-Day Moving Average | 40.67 |
| Relative Strength Index (RSI) | 56.64 |
| Average Volume (20 Days) | 3,342 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, CHGCF had revenue of 8.16 billion and earned 2.74 billion in profits. Earnings per share was 1.66.
| Revenue | 8.16B |
| Gross Profit | 5.80B |
| Operating Income | 3.87B |
| Pretax Income | 3.87B |
| Net Income | 2.74B |
| EBITDA | 4.04B |
| EBIT | 3.87B |
| Earnings Per Share (EPS) | 1.66 |
Balance Sheet
The company has 6.31 billion in cash and n/a in debt, giving a net cash position of 6.31 billion.
| Cash & Cash Equivalents | 6.31B |
| Total Debt | n/a |
| Net Cash | 6.31B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 12.74B |
| Book Value Per Share | 7.74 |
| Working Capital | 8.73B |
Cash Flow
In the last 12 months, operating cash flow was 2.76 billion and capital expenditures -404.37 million, giving a free cash flow of 2.36 billion.
| Operating Cash Flow | 2.76B |
| Capital Expenditures | -404.37M |
| Free Cash Flow | 2.36B |
| FCF Per Share | n/a |
Margins
Gross margin is 71.01%, with operating and profit margins of 47.36% and 33.56%.
| Gross Margin | 71.01% |
| Operating Margin | 47.36% |
| Pretax Margin | 47.37% |
| Profit Margin | 33.56% |
| EBITDA Margin | 49.52% |
| EBIT Margin | 47.36% |
| FCF Margin | 28.87% |
Dividends & Yields
This stock pays an annual dividend of 1.23, which amounts to a dividend yield of 2.56%.
| Dividend Per Share | 1.23 |
| Dividend Yield | 2.56% |
| Dividend Growth (YoY) | 128.40% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 39.42% |
| Buyback Yield | -0.01% |
| Shareholder Yield | 2.56% |
| Earnings Yield | 2.96% |
| FCF Yield | 2.55% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
CHGCF has an Altman Z-Score of 30.4.
| Altman Z-Score | 30.4 |
| Piotroski F-Score | n/a |